Loading…

Leukocyte-derived koebnerisin (S100A15) and psoriasin (S100A7) are systemic mediators of inflammation in psoriasis

Highlights • Leukocytes are a novel source of koebnerisin (S100A15) and psoriasin (S100A7). • Koebnerisin and psoriasin are induced in leukocytes of patients with psoriasis. • Koebnerisin but not psoriasin regulation marks PASI improvement by UVB therapy. • Koebnerisin and psoriasin act as ‘alarmins...

Full description

Saved in:
Bibliographic Details
Published in:Journal of dermatological science 2015-09, Vol.79 (3), p.214-221
Main Authors: Batycka-Baran, Aleksandra, Hattinger, Eva, Zwicker, Stephanie, Summer, Burkhard, Zack Howard, O.M, Thomas, Peter, Szepietowski, Jacek C, Ruzicka, Thomas, Prinz, Jörg C, Wolf, Ronald
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Highlights • Leukocytes are a novel source of koebnerisin (S100A15) and psoriasin (S100A7). • Koebnerisin and psoriasin are induced in leukocytes of patients with psoriasis. • Koebnerisin but not psoriasin regulation marks PASI improvement by UVB therapy. • Koebnerisin and psoriasin act as ‘alarmins’ on leukocytes to produce proinflammatory cytokines. • Koebnerisin and psoriasin are multifunctional mediators of inflammation.
ISSN:0923-1811
1873-569X
DOI:10.1016/j.jdermsci.2015.05.007